OK

OnKure Therapeutics, Inc.

OKUR · Nasdaq

OnKure Therapeutics, Inc. (OKUR) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for OnKure Therapeutics, Inc. in 2026. The next earnings report is expected on November 5, 2026.

Earnings calendar

Next earnings date

05 Nov 2026

In 78 days

EPS estimate

-0.54

Revenue estimate

166.7K

Past earnings

04 Aug 2026
EPS actual
-0.31 (+42.1%)
estimate -0.54
Revenue actual
0 (-100.0%)
estimate 166.7K
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
05 May 2026
EPS actual
-1.11 (-49.5%)
estimate -0.74
Revenue actual
0 (-100.0%)
estimate 166.7K
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
12 Mar 2026
EPS actual
-0.99 (+14.1%)
estimate -1.15
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
06 Nov 2025
EPS actual
-1.09 (+9.0%)
estimate -1.20
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Latest earnings analysis

OnKure Therapeutics beat consensus EPS estimates with EPS of $-0.31 versus an estimate of $-0.535, but missed revenue expectations as revenue came in at $0 against an estimate of $166.67 thousand, falling 100.0% short of expectations. In the previous report both EPS and revenue also came in below expectations.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

OnKure, Inc. engages in the discovery and development of oncology-precision medicines for the treatment of cancer. The company focuses on developing selective inhibitors of histone deacetylases. Its portfolio includes OKI-179, an inhibitor for the treatment of both hematological and solid tumors. The company was incorporated in 2011 and is based in Boulder, Colorado.

Sector
Healthcare
Industry
Biotechnology
Country
United States
Exchange
Nasdaq
CEO
Nicholas A. Saccomano
Employees
46
IPO date
08 Apr 2021
ISIN
US68277Q1058
Website
onkuretherapeutics.com

Frequently asked questions

When does OnKure Therapeutics, Inc. (OKUR) next report earnings?

OnKure Therapeutics, Inc. (OKUR) is scheduled to report earnings on November 5, 2026.

What was OnKure Therapeutics, Inc.'s most recent earnings date?

OnKure Therapeutics, Inc. (OKUR) last reported earnings on August 4, 2026.

Where is OnKure Therapeutics, Inc. stock listed?

OnKure Therapeutics, Inc. (OKUR) is listed on Nasdaq.